Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients

Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients: Results of a Pilot, Pragmatic, Randomized, Open Label, Controlled Trial Investigating Acceptability and Feasibility

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05715554

Enrollment

Registered

2023-02-08

Start date

2022-08-06

Completion date

2023-01-12

Last updated

2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-COVID Syndrome

Keywords

Rehabilitation, Homeopathy, Post-COVID Syndrome

Brief summary

A growing number of studies identify a spectrum of persistent symptoms experienced by COVID-19 patients for months after recovery. Symptoms include cough, fatigue, dyspnea, pain, and brain fog (cognitive impairment, including confusion and memory loss), which have a negative impact on daily activities. Homoeopathic practitioners from around the world have documented a number of successful cases of Post COVID treatment. Even though evidence from practice-based research is limited, the purpose of the current study was to evaluate the effect of individualized homoeopathy treatment on post-COVID syndrome.

Interventions

OTHERHomeopathy

Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Confirmed COVID-19 history * Persistent respiratory symptoms for more than three months after COVID-19 * Able to provide informed consent

Exclusion criteria

* Presence of respiratory issues without COVID-19 diagnosis * On complementary and Alternative Treatment * Symptoms of infection * Pregnancy or Breastfeeding * Cognitive impairment

Design outcomes

Primary

Measure	Time frame	Description
Cough severity	8 weeks	Severity from 0-10 visual analog scale, where 0 is none to 10 is most severe.

Secondary

Measure	Time frame	Description
Change in dyspnea	8 weeks	Change in dyspnea using Modified Borg Scale (0 is best to 10 is wore)
Change in Fatigue	8 weeks	Change in fatigue severity scale (0 -7 no fatigue to worse )
change in Quality of Life	8 weeks	Saint George Respiratory Questionnaire (SGRQ)to assess the quality of life (scores ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life).

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026